Humacyte Inc. (NASDAQ: HUMA)
$8.55
-0.2450 ( -2.79% ) 913.9K
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.
Market Data
Open
$8.55
Previous close
$8.79
Volume
913.9K
Market cap
$1.02B
Day range
$8.35 - $8.86
52 week range
$1.96 - $9.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 15, 2023 |
8-k | 8K-related | 15 | Sep 12, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
4 | Insider transactions | 1 | Aug 21, 2023 |
10-q | Quarterly Reports | 78 | Aug 14, 2023 |
8-k | 8K-related | 15 | Aug 14, 2023 |
8-k | 8K-related | 15 | Jul 26, 2023 |